187 related articles for article (PubMed ID: 38783251)
1. Prospective associations of leucocyte subtypes and obesity with the risk of developing cutaneous malignant melanoma in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Riboli E
BMC Cancer; 2024 May; 24(1):625. PubMed ID: 38783251
[TBL] [Abstract][Full Text] [Related]
2. Associations of obesity and body shape with erythrocyte and reticulocyte parameters in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
BMC Endocr Disord; 2023 Aug; 23(1):161. PubMed ID: 37528422
[TBL] [Abstract][Full Text] [Related]
3. A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
Cancer Med; 2021 Aug; 10(16):5614-5628. PubMed ID: 34196490
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in the associations of body size and body shape with platelets in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
Biol Sex Differ; 2023 Feb; 14(1):12. PubMed ID: 36814334
[TBL] [Abstract][Full Text] [Related]
5. Interactions of platelets with obesity in relation to lung cancer risk in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
Respir Res; 2023 Oct; 24(1):249. PubMed ID: 37848891
[TBL] [Abstract][Full Text] [Related]
6. Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
Cancer Med; 2024 Feb; 13(3):e6918. PubMed ID: 38234143
[TBL] [Abstract][Full Text] [Related]
7. Association of body-shape phenotypes with imaging measures of body composition in the UK Biobank cohort: relevance to colon cancer risk.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
BMC Cancer; 2021 Oct; 21(1):1106. PubMed ID: 34654381
[TBL] [Abstract][Full Text] [Related]
8. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S; Tsilidis KK; Dossus L; Rinaldi S; Weiderpass E; Antoniussen CS; Dahm CC; Tjønneland A; Mellemkjær L; Katzke V; Kaaks R; Schulze MB; Masala G; Grioni S; Panico S; Tumino R; Sacerdote C; May AM; Monninkhof EM; Quirós JR; Bonet C; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Rosendahl AH; Stocks T; Perez-Cornago A; Tin Tin S; Heath AK; Aglago EK; Peruchet-Noray L; Freisling H; Riboli E
BMC Cancer; 2023 Jun; 23(1):562. PubMed ID: 37337133
[TBL] [Abstract][Full Text] [Related]
9. Associations of A Body Shape Index (ABSI) with Cancer Incidence, All-Cause, and at 23 Sites-Findings from the UK Biobank Prospective Cohort Study.
Parra-Soto S; Malcomson FC; Ho FK; Pell JP; Sharp L; Mathers JC; Celis-Morales C
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):315-324. PubMed ID: 34853021
[TBL] [Abstract][Full Text] [Related]
10. Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
Sanikini H; Muller DC; Chadeau-Hyam M; Murphy N; Gunter MJ; Cross AJ
PLoS One; 2020; 15(10):e0240413. PubMed ID: 33079929
[TBL] [Abstract][Full Text] [Related]
11. Associations of body shape index (ABSI) and hip index with liver, metabolic, and inflammatory biomarkers in the UK Biobank cohort.
Christakoudi S; Riboli E; Evangelou E; Tsilidis KK
Sci Rep; 2022 May; 12(1):8812. PubMed ID: 35614088
[TBL] [Abstract][Full Text] [Related]
12. Associations of body shape phenotypes with sex steroids and their binding proteins in the UK Biobank cohort.
Christakoudi S; Riboli E; Evangelou E; Tsilidis KK
Sci Rep; 2022 Jun; 12(1):10774. PubMed ID: 35750890
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.
Fontvieille E; Viallon V; Recalde M; Cordova R; Jansana A; Peruchet-Noray L; Lennon H; Heath AK; Aune D; Christakoudi S; Katzke V; Kaaks R; Inan-Eroglu E; Schulze MB; Mellemkjær L; Tjønneland A; Overvad K; Farràs M; Petrova D; Amiano P; Chirlaque MD; Moreno-Iribas C; Tin Tin S; Masala G; Sieri S; Ricceri F; Panico S; May AM; Monninkhof EM; Weiderpass E; Gunter MJ; Ferrari P; Freisling H
BMC Med; 2023 Nov; 21(1):418. PubMed ID: 37993940
[TBL] [Abstract][Full Text] [Related]
14. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
15. A comparison of obesity indices in relation to mortality in type 2 diabetes: the Fremantle Diabetes Study.
Tate J; Knuiman M; Davis WA; Davis TME; Bruce DG
Diabetologia; 2020 Mar; 63(3):528-536. PubMed ID: 31838571
[TBL] [Abstract][Full Text] [Related]
16. Ultra-processed food consumption and risk of obesity: a prospective cohort study of UK Biobank.
Rauber F; Chang K; Vamos EP; da Costa Louzada ML; Monteiro CA; Millett C; Levy RB
Eur J Nutr; 2021 Jun; 60(4):2169-2180. PubMed ID: 33070213
[TBL] [Abstract][Full Text] [Related]
17. Central adiposity and the overweight risk paradox in aging: follow-up of 130,473 UK Biobank participants.
Bowman K; Atkins JL; Delgado J; Kos K; Kuchel GA; Ble A; Ferrucci L; Melzer D
Am J Clin Nutr; 2017 Jul; 106(1):130-135. PubMed ID: 28566307
[No Abstract] [Full Text] [Related]
18. Overweight, obesity, and individual symptoms of depression: A multicohort study with replication in UK Biobank.
Frank P; Jokela M; Batty GD; Lassale C; Steptoe A; Kivimäki M
Brain Behav Immun; 2022 Oct; 105():192-200. PubMed ID: 35853559
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Risk Factors Associated With Venous Thromboembolism.
Gregson J; Kaptoge S; Bolton T; Pennells L; Willeit P; Burgess S; Bell S; Sweeting M; Rimm EB; Kabrhel C; Zöller B; Assmann G; Gudnason V; Folsom AR; Arndt V; Fletcher A; Norman PE; Nordestgaard BG; Kitamura A; Mahmoodi BK; Whincup PH; Knuiman M; Salomaa V; Meisinger C; Koenig W; Kavousi M; Völzke H; Cooper JA; Ninomiya T; Casiglia E; Rodriguez B; Ben-Shlomo Y; Després JP; Simons L; Barrett-Connor E; Björkelund C; Notdurfter M; Kromhout D; Price J; Sutherland SE; Sundström J; Kauhanen J; Gallacher J; Beulens JWJ; Dankner R; Cooper C; Giampaoli S; Deen JF; Gómez de la Cámara A; Kuller LH; Rosengren A; Svensson PJ; Nagel D; Crespo CJ; Brenner H; Albertorio-Diaz JR; Atkins R; Brunner EJ; Shipley M; Njølstad I; Lawlor DA; van der Schouw YT; Selmer RM; Trevisan M; Verschuren WMM; Greenland P; Wassertheil-Smoller S; Lowe GDO; Wood AM; Butterworth AS; Thompson SG; Danesh J; Di Angelantonio E; Meade T;
JAMA Cardiol; 2019 Feb; 4(2):163-173. PubMed ID: 30649175
[TBL] [Abstract][Full Text] [Related]
20. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
McQuade JL; Daniel CR; Hess KR; Mak C; Wang DY; Rai RR; Park JJ; Haydu LE; Spencer C; Wongchenko M; Lane S; Lee DY; Kaper M; McKean M; Beckermann KE; Rubinstein SM; Rooney I; Musib L; Budha N; Hsu J; Nowicki TS; Avila A; Haas T; Puligandla M; Lee S; Fang S; Wargo JA; Gershenwald JE; Lee JE; Hwu P; Chapman PB; Sosman JA; Schadendorf D; Grob JJ; Flaherty KT; Walker D; Yan Y; McKenna E; Legos JJ; Carlino MS; Ribas A; Kirkwood JM; Long GV; Johnson DB; Menzies AM; Davies MA
Lancet Oncol; 2018 Mar; 19(3):310-322. PubMed ID: 29449192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
